Tissue persistence of parvovirus B19 genotypes in asymptomatic persons
暂无分享,去创建一个
V. de Giorgi | K. Zakrzewska | A. Azzi | M. Innocenti | F. Corcioli | R. Civinini | S. di Lollo | R. Fanci | A. Rinieri | Alessio Rinieri
[1] W. Poller,et al. Prevalence of erythrovirus genotypes in the myocardium of patients with dilated cardiomyopathy , 2008, Journal of medical virology.
[2] R. Tolba,et al. Simultaneous persistence of multiple genome variants of human parvovirus B19. , 2008, The Journal of general virology.
[3] A. Ekman,et al. Biological and Immunological Relations among Human Parvovirus B19 Genotypes 1 to 3 , 2007, Journal of Virology.
[4] S. Modrow,et al. Human parvovirus B19 infection and antiphospholipid antibodies. , 2007, Autoimmunity reviews.
[5] I. Ercan,et al. Detection of parvovirus B19 DNA in the lesional skin of patients with Behçet's disease , 2007, Clinical and experimental dermatology.
[6] K. Broliden,et al. Clinical aspects of parvovirus B19 infection , 2006, Journal of internal medicine.
[7] A. Vaheri,et al. Bioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[8] Brian D. Poole,et al. Apoptosis of Liver-Derived Cells Induced by Parvovirus B19 Nonstructural Protein , 2006, Journal of Virology.
[9] E. Sabino,et al. Sequence Variability of Human Erythroviruses Present in Bone Marrow of Brazilian Patients with Various Parvovirus B19-Related Hematological Symptoms , 2006, Journal of Clinical Microbiology.
[10] E. Delwart,et al. Novel Parvovirus and Related Variant in Human Plasma , 2006, Emerging infectious diseases.
[11] S. Modrow. Parvovirus B19: the causative agent of dilated cardiomyopathy or a harmless passenger of the human myocard? , 2006, Ernst Schering Research Foundation workshop.
[12] A. Isa,et al. Slow clearance of human parvovirus B19 viremia following acute infection. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[13] J. Lefrère,et al. Persistent B19 infection in immunocompetent individuals: implications for transfusion safety. , 2005, Blood.
[14] M. Tammi,et al. Cloning of a human parvovirus by molecular screening of respiratory tract samples. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[15] J. Kerr. Pathogenesis of parvovirus B19 infection: host gene variability, and possible means and effects of virus persistence. , 2005, Journal of veterinary medicine. B, Infectious diseases and veterinary public health.
[16] P. Simmonds,et al. New DNA Viruses Identified in Patients with Acute Viral Infection Syndrome , 2005, Journal of Virology.
[17] R. Kandolf,et al. High Prevalence of Viral Genomes and Multiple Viral Infections in the Myocardium of Adults With “Idiopathic” Left Ventricular Dysfunction , 2005, Circulation.
[18] C. Tschöpe,et al. High Prevalence of Cardiac Parvovirus B19 Infection in Patients With Isolated Left Ventricular Diastolic Dysfunction , 2005, Circulation.
[19] A. Parsyan,et al. Identification and Characterization of Persistent Human Erythrovirus Infection in Blood Donor Samples , 2004, Journal of Virology.
[20] T. Ohtsuka,et al. Increased prevalence of human parvovirus B19 DNA in systemic sclerosis skin , 2004, The British journal of dermatology.
[21] H. Gabbert,et al. Frequency and quantity of the parvovirus B19 genome in endomyocardial biopsies from patients with suspected myocarditis or idiopathic left ventricular dysfunction , 2004, Zeitschrift für Kardiologie.
[22] H. Figulla,et al. Frequent detection of parvovirus B19 genome in the myocardium of adult patients with idiopathic dilated cardiomyopathy , 2004, Medical Microbiology and Immunology.
[23] S. Modrow,et al. Parvovirus B19 infection and autoimmune disease. , 2003, Autoimmunity reviews.
[24] B. Maisch,et al. Prevalence of the parvovirus B19 genome in endomyocardial biopsy specimens. , 2003, Human pathology.
[25] M. Söderlund-Venermo,et al. A new parvovirus genotype persistent in human skin. , 2002, Virology.
[26] Quang Tri Nguyen,et al. Identification and characterization of a second novel human erythrovirus variant, A6. , 2002, Virology.
[27] S. Laperche,et al. Genetic Diversity within Human Erythroviruses: Identification of Three Genotypes , 2002, Journal of Virology.
[28] S. Nikkari,et al. Presence of parvovirus B19 DNA in chronic urticaric and healthy human skin. , 2002, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[29] M. Söderlund-Venermo,et al. Persistence of human parvovirus B19 in human tissues. , 2002, Pathologie-biologie.
[30] K. Zakrzewska,et al. Persistence of parvovirus B19 DNA in synovium of patients with haemophilic arthritis , 2001, Journal of medical virology.
[31] S. Koenig,et al. Quantitative analysis of neutralizing immune responses to human parvovirus B19 using a novel reverse transcriptase-polymerase chain reaction-based assay. , 1999, The Journal of infectious diseases.
[32] K. Hedman,et al. Prevalence of parvovirus B19 DNA in bone marrow of patients with haematological disorders. , 1999, Scandinavian journal of infectious diseases.
[33] K. Broliden,et al. Clinical and laboratory findings in immunocompetent patients with persistent parvovirus B19 DNA in bone marrow. , 1999, Scandinavian journal of infectious diseases.
[34] T. Pumarola. Parvovirus B19 , 1999, Transfusion Medicine and Hemotherapy.
[35] Quang Tri Nguyen,et al. Detection of an erythrovirus sequence distinct from B19 in a child with acute anaemia , 1998, The Lancet.
[36] G. Siegl,et al. Presence and significance of human parvovirus B19 DNA in synovial membranes and bone marrow from patients with arthritis of unknown origin , 1998, Journal of medical virology.
[37] K. Zakrzewska,et al. Typing of European strains of parvovirus B19 by restriction endonuclease analyses and sequencing: identification of evolutionary lineages and evidence of recombination of markers from different lineages. , 1998, Virus research.
[38] G. Siegl,et al. Evidence for persistence of human parvovirus B19 DNA in bone marrow , 1997, Journal of medical virology.
[39] K. Hedman,et al. Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy , 1997, The Lancet.
[40] S. Modrow,et al. Sequence variability among different parvovirus B19 isolates. , 1996, The Journal of general virology.
[41] M. Zerbini,et al. Parvovirus B19 clearance from peripheral blood after acute infection. , 1995, The Journal of infectious diseases.
[42] A. Reingold,et al. Genital human papillomavirus infection in female university students as determined by a PCR‐based method , 1991, JAMA.
[43] A. Woolf. Human parvovirus B19 and arthritis. , 1990, Behring Institute Mitteilungen.
[44] N. Young,et al. Chronic bone marrow failure due to persistent B19 parvovirus infection. , 1987, The New England journal of medicine.
[45] J. Clewley,et al. INTRAUTERINE PARVOVIRUS INFECTION ASSOCIATED WITH HYDROPS FETALIS , 1984, The Lancet.
[46] M. Anderson,et al. HUMAN PARVOVIRUS, THE CAUSE OF ERYTHEMA INFECTIOSUM (FIFTH DISEASE)? , 1983, The Lancet.
[47] S. Jones,et al. OUTBREAK OF APLASTIC CRISES IN SICKLE CELL ANAEMIA ASSOCIATED WITH PARVOVIRUS-LIKE AGENT , 1981, The Lancet.
[48] P. Hochstein,et al. POTENTIAL VARIANTS OF PHENYLKETONURIA , 1975, The Lancet.
[49] Bender Ae. Letter: Protein requirement. , 1974 .